JP2006512357A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006512357A5 JP2006512357A5 JP2004561828A JP2004561828A JP2006512357A5 JP 2006512357 A5 JP2006512357 A5 JP 2006512357A5 JP 2004561828 A JP2004561828 A JP 2004561828A JP 2004561828 A JP2004561828 A JP 2004561828A JP 2006512357 A5 JP2006512357 A5 JP 2006512357A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- dihydro
- thioxo
- phenyl
- oxo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000001875 compounds Chemical class 0.000 claims 15
- -1 4-pyridinyl Chemical group 0.000 claims 11
- 125000000217 alkyl group Chemical group 0.000 claims 7
- 229910052739 hydrogen Inorganic materials 0.000 claims 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 5
- 229910052799 carbon Inorganic materials 0.000 claims 4
- 125000006545 (C1-C9) alkyl group Chemical group 0.000 claims 3
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 3
- 125000003342 alkenyl group Chemical group 0.000 claims 3
- 125000000304 alkynyl group Chemical group 0.000 claims 3
- 125000001624 naphthyl group Chemical group 0.000 claims 3
- 125000006580 bicyclic heterocycloalkyl group Chemical group 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- AZHNJGMAHPCYTO-UHFFFAOYSA-N (4-methoxycarbonylphenyl) 6-[(4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene)methyl]-2,3-dihydro-1,4-benzoxazine-4-carboxylate Chemical compound C1=CC(C(=O)OC)=CC=C1OC(=O)N1C2=CC(C=C3C(NC(=S)S3)=O)=CC=C2OCC1 AZHNJGMAHPCYTO-UHFFFAOYSA-N 0.000 claims 1
- SZJWGDUDJSGXGD-UHFFFAOYSA-N (4-methylphenyl) 6-[(4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene)methyl]-2,3-dihydro-1,4-benzoxazine-4-carboxylate Chemical compound C1=CC(C)=CC=C1OC(=O)N1C2=CC(C=C3C(NC(=S)S3)=O)=CC=C2OCC1 SZJWGDUDJSGXGD-UHFFFAOYSA-N 0.000 claims 1
- 102000010400 1-phosphatidylinositol-3-kinase activity proteins Human genes 0.000 claims 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 claims 1
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims 1
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 claims 1
- 125000003682 3-furyl group Chemical group O1C([H])=C([*])C([H])=C1[H] 0.000 claims 1
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 claims 1
- SCBNEBCVYMOMFL-UHFFFAOYSA-N 5-[(4-heptanoyl-2,3-dihydro-1,4-benzoxazin-6-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one Chemical compound C1=C2N(C(=O)CCCCCC)CCOC2=CC=C1C=C1SC(=S)NC1=O SCBNEBCVYMOMFL-UHFFFAOYSA-N 0.000 claims 1
- PKHANDDFNUXAFV-UHFFFAOYSA-N 5-[(4-pentanoyl-2,3-dihydro-1,4-benzoxazin-6-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one Chemical compound C1=C2N(C(=O)CCCC)CCOC2=CC=C1C=C1SC(=S)NC1=O PKHANDDFNUXAFV-UHFFFAOYSA-N 0.000 claims 1
- UWKBMECNTWQSLY-UHFFFAOYSA-N 5-[[4-(2-methylpropanoyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one Chemical compound C1=C2N(C(=O)C(C)C)CCOC2=CC=C1C=C1SC(=S)NC1=O UWKBMECNTWQSLY-UHFFFAOYSA-N 0.000 claims 1
- WFJYMLNJPHSLNA-UHFFFAOYSA-N 5-[[4-(2-phenylmethoxyacetyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one Chemical compound C1COC2=CC=C(C=C3C(NC(=S)S3)=O)C=C2N1C(=O)COCC1=CC=CC=C1 WFJYMLNJPHSLNA-UHFFFAOYSA-N 0.000 claims 1
- LYJCNRVAIPWBKM-UHFFFAOYSA-N 5-[[4-(2-phenylsulfanylacetyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one Chemical compound C1COC2=CC=C(C=C3C(NC(=S)S3)=O)C=C2N1C(=O)CSC1=CC=CC=C1 LYJCNRVAIPWBKM-UHFFFAOYSA-N 0.000 claims 1
- GMMCWLUTYRNKNT-UHFFFAOYSA-N 5-[[4-(3-cyclopentylpropanoyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one Chemical compound C1COC2=CC=C(C=C3C(NC(=S)S3)=O)C=C2N1C(=O)CCC1CCCC1 GMMCWLUTYRNKNT-UHFFFAOYSA-N 0.000 claims 1
- UBDWHOTZVUMAGD-UHFFFAOYSA-N 5-[[4-(3-phenylprop-2-enoyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one Chemical compound C1COC2=CC=C(C=C3C(NC(=S)S3)=O)C=C2N1C(=O)C=CC1=CC=CC=C1 UBDWHOTZVUMAGD-UHFFFAOYSA-N 0.000 claims 1
- 125000006163 5-membered heteroaryl group Chemical group 0.000 claims 1
- ABMAEMXZZIQZAW-UHFFFAOYSA-N 6-[(4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene)methyl]-n-(2-phenylethyl)-2,3-dihydro-1,4-benzoxazine-4-carboxamide Chemical compound C1COC2=CC=C(C=C3C(NC(=S)S3)=O)C=C2N1C(=O)NCCC1=CC=CC=C1 ABMAEMXZZIQZAW-UHFFFAOYSA-N 0.000 claims 1
- BOJXKPUZPWUBKG-UHFFFAOYSA-N 6-[(4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene)methyl]-n-[3-(trifluoromethyl)phenyl]-2,3-dihydro-1,4-benzoxazine-4-carboxamide Chemical compound FC(F)(F)C1=CC=CC(NC(=O)N2C3=CC(C=C4C(NC(=S)S4)=O)=CC=C3OCC2)=C1 BOJXKPUZPWUBKG-UHFFFAOYSA-N 0.000 claims 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 1
- 239000005977 Ethylene Substances 0.000 claims 1
- 108091007960 PI3Ks Proteins 0.000 claims 1
- KPCZJLGGXRGYIE-UHFFFAOYSA-N [C]1=CC=CN=C1 Chemical group [C]1=CC=CN=C1 KPCZJLGGXRGYIE-UHFFFAOYSA-N 0.000 claims 1
- 125000004601 benzofurazanyl group Chemical group N1=C2C(=NO1)C(=CC=C2)* 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 claims 1
- YMPZGWKUVRLVKJ-UHFFFAOYSA-N methyl 8-oxo-8-[6-[(4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene)methyl]-2,3-dihydro-1,4-benzoxazin-4-yl]octanoate Chemical compound C1=C2N(C(=O)CCCCCCC(=O)OC)CCOC2=CC=C1C=C1SC(=S)NC1=O YMPZGWKUVRLVKJ-UHFFFAOYSA-N 0.000 claims 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims 1
- NPGBBBUQVSTPBS-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-[(4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene)methyl]-2,3-dihydro-1,4-benzoxazine-4-carboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1NC(=O)N1C2=CC(C=C3C(NC(=S)S3)=O)=CC=C2OCC1 NPGBBBUQVSTPBS-UHFFFAOYSA-N 0.000 claims 1
- BSTXURKZHUFJNL-UHFFFAOYSA-N n-(3,5-dimethylphenyl)-6-[(4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene)methyl]-2,3-dihydro-1,4-benzoxazine-4-carboxamide Chemical compound CC1=CC(C)=CC(NC(=O)N2C3=CC(C=C4C(NC(=S)S4)=O)=CC=C3OCC2)=C1 BSTXURKZHUFJNL-UHFFFAOYSA-N 0.000 claims 1
- GSMHWGJGKAOCFZ-UHFFFAOYSA-N n-(3-chlorophenyl)-6-[(4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene)methyl]-2,3-dihydro-1,4-benzoxazine-4-carboxamide Chemical compound ClC1=CC=CC(NC(=O)N2C3=CC(C=C4C(NC(=S)S4)=O)=CC=C3OCC2)=C1 GSMHWGJGKAOCFZ-UHFFFAOYSA-N 0.000 claims 1
- OMCSAMOTVJTYBH-UHFFFAOYSA-N n-(4-chlorophenyl)-6-[(4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene)methyl]-2,3-dihydro-1,4-benzoxazine-4-carboxamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)N1C2=CC(C=C3C(NC(=S)S3)=O)=CC=C2OCC1 OMCSAMOTVJTYBH-UHFFFAOYSA-N 0.000 claims 1
- KNTWQLFICXLUMJ-UHFFFAOYSA-N n-cyclopentyl-6-[(4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene)methyl]-2,3-dihydro-1,4-benzoxazine-4-carboxamide Chemical compound C1COC2=CC=C(C=C3C(NC(=S)S3)=O)C=C2N1C(=O)NC1CCCC1 KNTWQLFICXLUMJ-UHFFFAOYSA-N 0.000 claims 1
- XSDJJZZCSAQENW-UHFFFAOYSA-N naphthalen-1-yl 6-[(4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene)methyl]-2,3-dihydro-1,4-benzoxazine-4-carboxylate Chemical compound C=1C=CC2=CC=CC=C2C=1OC(=O)N(C1=C2)CCOC1=CC=C2C=C1SC(=S)NC1=O XSDJJZZCSAQENW-UHFFFAOYSA-N 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- ADHBQTVRFHHGSD-UHFFFAOYSA-N phenyl 6-[(4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene)methyl]-2,3-dihydro-1,4-benzoxazine-4-carboxylate Chemical compound C1COC2=CC=C(C=C3C(NC(=S)S3)=O)C=C2N1C(=O)OC1=CC=CC=C1 ADHBQTVRFHHGSD-UHFFFAOYSA-N 0.000 claims 1
- 125000003386 piperidinyl group Chemical group 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43522702P | 2002-12-20 | 2002-12-20 | |
| PCT/IB2003/005887 WO2004056820A1 (en) | 2002-12-20 | 2003-12-10 | Benzoxazines and derivatives thereof as inhibitors of pi3ks |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006512357A JP2006512357A (ja) | 2006-04-13 |
| JP2006512357A5 true JP2006512357A5 (enExample) | 2007-02-01 |
Family
ID=32682185
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004561828A Abandoned JP2006512357A (ja) | 2002-12-20 | 2003-12-10 | Ｐｉ３ｋの阻害剤としてのベンゾキサジンおよびその誘導体 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20040138199A1 (enExample) |
| EP (1) | EP1581529A1 (enExample) |
| JP (1) | JP2006512357A (enExample) |
| AU (1) | AU2003303231A1 (enExample) |
| BR (1) | BR0317572A (enExample) |
| CA (1) | CA2510851A1 (enExample) |
| MX (1) | MXPA05006742A (enExample) |
| WO (1) | WO2004056820A1 (enExample) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6667300B2 (en) | 2000-04-25 | 2003-12-23 | Icos Corporation | Inhibitors of human phosphatidylinositol 3-kinase delta |
| EP1648422A4 (en) * | 2003-07-28 | 2007-09-19 | Reddys Lab Inc Dr | TREATMENT AND PREVENTION OF CARDIOVASCULAR ACCIDENTS |
| WO2005016348A1 (en) * | 2003-08-14 | 2005-02-24 | Icos Corporation | Method of inhibiting immune responses stimulated by an endogenous factor |
| US7914831B2 (en) | 2004-02-27 | 2011-03-29 | Metaproteomics, Llc | Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines |
| CA2566436C (en) * | 2004-05-13 | 2011-05-10 | Vanderbilt University | Phosphoinositide 3-kinase delta selective inhibitors for inhibiting angiogenesis |
| PL1761540T3 (pl) | 2004-05-13 | 2017-06-30 | Icos Corporation | Chinazolinony jako inhibitory ludzkiej kinazy 3-fosfatydyloinozytolu delta |
| US7842698B2 (en) | 2004-09-03 | 2010-11-30 | Merck Serono S.A. | Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors |
| US7691888B2 (en) | 2004-10-07 | 2010-04-06 | Boehringer Ingelheim International Gmbh | Thiazolyl-dihydro-indazole |
| EP1885356A2 (en) * | 2005-02-17 | 2008-02-13 | Icos Corporation | Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation |
| WO2007021694A2 (en) * | 2005-08-09 | 2007-02-22 | Metaproteomics, Llc | Protein kinase modulation by hops and acacia products |
| WO2007023186A1 (en) | 2005-08-26 | 2007-03-01 | Laboratoires Serono S.A. | Pyrazine derivatives and use as pi3k inhibitors |
| AU2006287765B2 (en) * | 2005-09-07 | 2011-12-08 | Merck Serono Sa | P13K inhibitors for the treatment of endometriosis |
| US20070116756A1 (en) * | 2005-11-23 | 2007-05-24 | Dr. Reddy's Laboratories Limited | Stable pharmaceutical compositions |
| CA2632684A1 (en) * | 2005-12-09 | 2007-06-14 | Metaproteomics, Llc | Protein kinase modulation by hops and acacia products |
| US7691868B2 (en) | 2006-04-06 | 2010-04-06 | Boehringer Ingelheim International Gmbh | Thiazolyl-dihydro-quinazoline |
| US7517995B2 (en) | 2006-04-06 | 2009-04-14 | Boehringer Ingelheim International Gmbh | Thiazolyl-dihydro-cyclopentapyrazole |
| US7601716B2 (en) * | 2006-05-01 | 2009-10-13 | Cephalon, Inc. | Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors |
| JP5508027B2 (ja) | 2007-02-22 | 2014-05-28 | メルク セローノ ソシエテ アノニム | キノキサリン化合物及びその使用 |
| WO2009026346A1 (en) * | 2007-08-20 | 2009-02-26 | Targegen Inc. | Thiazolidine compounds, and methods of making and using same |
| US20110172217A1 (en) * | 2008-09-05 | 2011-07-14 | Shionogi & Co., Ltd. | Ring-fused morpholine derivative having pi3k-inhibiting activity |
| US9492449B2 (en) | 2008-11-13 | 2016-11-15 | Gilead Calistoga Llc | Therapies for hematologic malignancies |
| NZ631024A (en) | 2008-11-13 | 2016-04-29 | Gilead Calistoga Llc | Therapies for hematologic malignancies |
| KR20110115160A (ko) | 2009-02-12 | 2011-10-20 | 메르크 세로노 에스. 에이. | 2-모르폴리노-피리도〔3,2-ｄ〕피리미딘 |
| SG174529A1 (en) | 2009-03-24 | 2011-10-28 | Gilead Calistoga Llc | Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use |
| PT2421536E (pt) | 2009-04-20 | 2015-10-20 | Gilead Calistoga Llc | Métodos de tratamento para tumores sólidos |
| BRPI1010896A2 (pt) * | 2009-05-26 | 2019-09-24 | Exelixis Inc | benzoxazepinas como inibidores de pi3k/mtor e métodos de seus usos e fabricação |
| EP2456443A1 (en) | 2009-07-21 | 2012-05-30 | Gilead Calistoga LLC | Treatment of liver disorders with pi3k inhibitors |
| AR078770A1 (es) | 2009-10-27 | 2011-11-30 | Elara Pharmaceuticals Gmbh | Derivados de dihidrobenzo oxacinas y tiazinas, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades inflamatorias e hiperproliferativas. |
| MX2012005518A (es) | 2009-11-13 | 2012-06-19 | Merck Serono Sa | Derivados de pirazol amina triciclica. |
| WO2012130306A1 (en) | 2011-03-30 | 2012-10-04 | Elara Pharmaceuticals Gmbh | Bicyclic 2,3-dihyrdobenzazine compounds for use in therapy |
| CN102731525A (zh) * | 2011-04-08 | 2012-10-17 | 上海艾力斯医药科技有限公司 | 苯并吗啉衍生物 |
| IN2014CN04174A (enExample) * | 2011-12-22 | 2015-09-04 | Novartis Ag | |
| AP2014007875A0 (en) | 2012-03-05 | 2014-08-31 | Gilead Calistoga Llc | Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one |
| PE20160546A1 (es) | 2013-10-25 | 2016-05-26 | Novartis Ag | Compuestos derivados de piridilo biciclicos fusionados a anillo como inhibidores de fgfr4 |
| US9422281B2 (en) | 2013-11-18 | 2016-08-23 | Forma Therapeutics, Inc. | Benzopiperazine compositions as BET bromodomain inhibitors |
| WO2015074064A2 (en) | 2013-11-18 | 2015-05-21 | Bair Kenneth W | Tetrahydroquinoline compositions as bet bromodomain inhibitors |
| PT3083630T (pt) | 2013-12-20 | 2019-11-15 | Gilead Calistoga Llc | Procedimentos para inibidores da fosfatidilinositol 3-quinase |
| EP3083623A1 (en) | 2013-12-20 | 2016-10-26 | Gilead Calistoga LLC | Polymorphic forms of a hydrochloride salt of (s) -2-(9h-purin-6-ylamino) propyl) -5-fluoro-3-phenylquinazolin-4 (3h) -one |
| MX2016010998A (es) | 2014-02-27 | 2017-03-31 | Lycera Corp | Terapia celular adoptiva que usa un agonista de receptor huérfano gamma relacionado con receptor de ácido retinoico y métodos terapéuticos relacionados. |
| US9896441B2 (en) | 2014-05-05 | 2018-02-20 | Lycera Corporation | Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease |
| JP6523337B2 (ja) | 2014-05-05 | 2019-05-29 | リセラ・コーポレイションＬｙｃｅｒａ Ｃｏｒｐｏｒａｔｉｏｎ | ＲＯＲγのアゴニストとしての使用及び疾患治療のためのベンゼンスルホンアミド及び関連化合物 |
| JP6455995B2 (ja) | 2014-06-13 | 2019-01-23 | ギリアード サイエンシーズ， インコーポレイテッド | ホスファチジルイノシトール３−キナーゼ阻害剤 |
| RS58274B1 (sr) * | 2014-06-30 | 2019-03-29 | Astrazeneca Ab | Benzoksazinon amidi kao modulatori mineralokortikoidnog receptora |
| JP6585167B2 (ja) | 2014-10-03 | 2019-10-02 | ノバルティス アーゲー | Ｆｇｆｒ４阻害剤としての縮環二環式ピリジル誘導体の使用 |
| US9802917B2 (en) | 2015-03-25 | 2017-10-31 | Novartis Ag | Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide |
| CA2982847A1 (en) | 2015-05-05 | 2016-11-10 | Lycera Corporation | Dihydro-2h-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of ror.gamma. and the treatment of disease |
| HK1253734A1 (zh) | 2015-06-11 | 2019-06-28 | The Regents Of The University Of Michigan | 用作RORγ激动剂和用於治疗疾病的芳基二氢-2H-苯并[B][1，4]恶嗪磺酰胺和相关化合物 |
| US11351156B2 (en) | 2017-10-13 | 2022-06-07 | Inserm | Combination treatment of pancreatic cancer |
| WO2019101871A1 (en) | 2017-11-23 | 2019-05-31 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | A new marker for predicting the sensitivity to pi3k inhibitors |
| WO2025087879A2 (en) | 2023-10-23 | 2025-05-01 | Institut National de la Santé et de la Recherche Médicale | Suppressing the pi3kgamma/akt signalling pathway for the treatment of acute myeloid leukemia |
| WO2025161263A1 (zh) * | 2024-01-31 | 2025-08-07 | 深圳晶蛋生物医药科技有限公司 | 一种苯并吗啉类化合物及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6355664B1 (en) * | 1997-03-03 | 2002-03-12 | Boehringer Ingelheim Pharmaceuticals, Inc. | Phenylpyrrolidines, phenylimidazolidines, 3-phenyl-1,3-oxizolidines and 3-phenyl-1,3-thiazolidines and their use in the treatment of inflammatory disease |
| MXPA02010618A (es) * | 2000-04-25 | 2004-05-05 | Icos Corp | Inhibidores de fosfatidilinositol 3-quinasa delta. |
| CN100345830C (zh) * | 2000-04-27 | 2007-10-31 | 安斯泰来制药有限公司 | 稠合杂芳基衍生物 |
| AU2003255528B2 (en) * | 2002-07-10 | 2009-07-16 | Merck Serono Sa | Azolidinone-vinyl fused-benzene derivatives |
| US20040092561A1 (en) * | 2002-11-07 | 2004-05-13 | Thomas Ruckle | Azolidinone-vinyl fused -benzene derivatives |
| EP1551396A1 (en) * | 2002-09-26 | 2005-07-13 | Pintex Pharmaceuticals, Inc. | Pin1-modulating compounds and methods of use thereof |
-
2003
- 2003-12-10 JP JP2004561828A patent/JP2006512357A/ja not_active Abandoned
- 2003-12-10 AU AU2003303231A patent/AU2003303231A1/en not_active Abandoned
- 2003-12-10 WO PCT/IB2003/005887 patent/WO2004056820A1/en not_active Ceased
- 2003-12-10 EP EP03813672A patent/EP1581529A1/en not_active Withdrawn
- 2003-12-10 CA CA002510851A patent/CA2510851A1/en not_active Abandoned
- 2003-12-10 BR BR0317572-3A patent/BR0317572A/pt not_active IP Right Cessation
- 2003-12-10 MX MXPA05006742A patent/MXPA05006742A/es not_active Application Discontinuation
- 2003-12-22 US US10/743,852 patent/US20040138199A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006512357A5 (enExample) | ||
| RU2320648C2 (ru) | 4,6,7,13-замещенные производные 1-бензил-изохинолина и фармацевтическая композиция, обладающая ингибирующей активностью в отношении гфат | |
| JP2005521642A5 (enExample) | ||
| PE20080951A1 (es) | DERIVADOS DE 2-OXO-ETIL-AMINO-PROPIONAMIDA-PIRROLIDIN-2-IL-SUSTITUIDOS COMO INHIBIDORES DEL ENLACE DE LA PROTEINA Smac AL INHIBIDOR DE LA PROTEINA DE APOPTOSIS | |
| RU2312106C2 (ru) | Замещенные 4-алкоксиоксазолпроизводные в качестве агонистов ppar | |
| RU2014142598A (ru) | Новые 4-метилдигидропиримидины для лечения и профилактики инфекции вируса гепатита в | |
| CA2652834A1 (en) | Substituted arylimidazolones and -triazolones and the use thereof | |
| JP2010539152A5 (enExample) | ||
| PE20080360A1 (es) | Derivados 4-bencilftalazinona 2-sustituidos como antagonistas de histaminas h1 y h3 | |
| NZ588652A (en) | Carboxamide compounds for the treatment of metabolic disorders | |
| JP2010215644A5 (enExample) | ||
| JP2007517010A5 (enExample) | ||
| JP2006517572A5 (enExample) | ||
| JP2007231005A5 (enExample) | ||
| WO2008103351A3 (en) | Heterocyclic aspartyl protease inhibitors | |
| JP2012525431A5 (enExample) | ||
| NZ589962A (en) | Inhibitors of stearoyl-CoA desaturase and uses thereof | |
| PE20120812A1 (es) | Compuestos vinil indazolilo | |
| JP2009519965A5 (enExample) | ||
| JP2009502948A5 (enExample) | ||
| PE20090617A1 (es) | Compuestos amino-5-[-4-(difluorometoxi)fenil]-5-fenilimidazolona para la inhibicion de -secretasa | |
| JP2004534035A5 (enExample) | ||
| JP2007516173A5 (enExample) | ||
| JP2006515604A5 (enExample) | ||
| JP2010504286A5 (enExample) |